Gene: Ankrd33b (ankyrin repeat domain 33B) Rattus norvegicus
Analyze
Symbol:
Ankrd33b
Name:
ankyrin repeat domain 33B
RGD ID:
1564227
Description:
Orthologous to human ANKRD33B (ankyrin repeat domain 33B); INTERACTS WITH 3-chloropropane-1,2-diol; 6-propyl-2-thiouracil; acetamide.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
ankyrin repeat domain-containing protein 33B; LOC310200; RGD1564227; similar to RIKEN cDNA 5730557B15
RGD Orthologs
Alliance Genes
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
ANKRD33B (ankyrin repeat domain 33B) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Ankrd33b (ankyrin repeat domain 33B) HGNC
Treefam, EggNOG, OrthoMCL, NCBI, OMA, HomoloGene, Inparanoid, Panther, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Ankrd33b (ankyrin repeat domain 33B) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
ANKRD33B (ankyrin repeat domain 33B) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
ANKRD33B (ankyrin repeat domain 33B) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Ankrd33b (ankyrin repeat domain 33B) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
ANKRD33B (ankyrin repeat domain 33B) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
ANKRD33B (ankyrin repeat domain 33B) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Ankrd33b (ankyrin repeat domain 33B) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
ANKRD33 (ankyrin repeat domain 33) HGNC
OrthoDB
Alliance orthologs 3
Mus musculus (house mouse):
Ankrd33b (ankyrin repeat domain 33B)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
ANKRD33B (ankyrin repeat domain 33B)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
ankrd33ba (ankyrin repeat domain 33ba)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
ankrd33bb (ankyrin repeat domain 33Bb)
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER|PhylomeDB)
Latest Assembly:
mRatBN7.2 - mRatBN7.2 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl mRatBN7.2 2 82,277,604 - 82,359,420 (-) NCBI mRatBN7.2 mRatBN7.2 Ensembl 2 82,283,108 - 82,358,872 (-) Ensembl Rnor_6.0 2 84,361,061 - 84,436,912 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 84,361,061 - 84,437,084 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 104,034,185 - 104,110,203 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 83,369,613 - 83,446,622 (-) NCBI RGSC3.4 rn4 RGSC3.4 Celera 2 77,806,510 - 77,882,181 (-) NCBI Celera Cytogenetic Map 2 q22 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
(-)-demecolcine increases expression ISO RGD:2307384 6480464 Demecolcine results in increased expression of ANKRD33B mRNA CTD PMID:23649840 1,2-dichloroethane decreases expression ISO RGD:1558105 6480464 ethylene dichloride results in decreased expression of ANKRD33B mRNA CTD PMID:28189721 , PMID:28960355 17beta-estradiol multiple interactions ISO RGD:2307384 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of ANKRD33B mRNA CTD PMID:30165855 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1558105 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ANKRD33B mRNA CTD PMID:20188158 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ANKRD33B mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol increases expression ISO RGD:1558105 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ANKRD33B mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO RGD:2307384 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of ANKRD33B gene CTD PMID:31601247 4,4'-sulfonyldiphenol increases methylation ISO RGD:1558105 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of ANKRD33B exon CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:1558105 6480464 Fenretinide results in increased expression of ANKRD33B mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ANKRD33B mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of ANKRD33B mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:2307384 6480464 Acrylamide results in increased expression of ANKRD33B mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:1558105 6480464 Aflatoxin B1 results in increased expression of ANKRD33B mRNA CTD PMID:19770486 aflatoxin B1 affects methylation ISO RGD:2307384 6480464 Aflatoxin B1 affects the methylation of ANKRD33B intron CTD PMID:30157460 aflatoxin B1 increases expression ISO RGD:2307384 6480464 Aflatoxin B1 results in increased expression of ANKRD33B mRNA CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO RGD:2307384 6480464 aflatoxin B2 results in increased methylation of ANKRD33B intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:2307384 6480464 Tretinoin results in increased expression of ANKRD33B mRNA CTD PMID:23830798 antirheumatic drug increases expression ISO RGD:2307384 6480464 Antirheumatic Agents results in increased expression of ANKRD33B mRNA CTD PMID:24449571 aristolochic acid decreases expression ISO RGD:2307384 6480464 aristolochic acid I results in decreased expression of ANKRD33B mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:2307384 6480464 Arsenic affects the methylation of ANKRD33B gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:2307384 6480464 Arsenic affects the methylation of ANKRD33B gene CTD PMID:25304211 benzo[a]pyrene increases expression ISO RGD:1558105 6480464 Benzo(a)pyrene results in increased expression of ANKRD33B mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO RGD:2307384 6480464 Benzo(a)pyrene results in increased expression of ANKRD33B mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:2307384 6480464 Benzo(a)pyrene affects the methylation of ANKRD33B 3' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:2307384 6480464 Benzo(a)pyrene results in increased methylation of ANKRD33B 5' UTR more ... CTD PMID:27901495 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ANKRD33B mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:2307384 6480464 bisphenol A results in decreased methylation of ANKRD33B gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1558105 6480464 bisphenol A results in increased expression of ANKRD33B mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ANKRD33B mRNA CTD PMID:34947998 bisphenol A decreases expression ISO RGD:1558105 6480464 bisphenol A results in decreased expression of ANKRD33B mRNA CTD PMID:30951980 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of ANKRD33B mRNA CTD PMID:32479839 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of ANKRD33B mRNA CTD PMID:19167457 carbamazepine affects expression ISO RGD:2307384 6480464 Carbamazepine affects the expression of ANKRD33B mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1558105 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 cisplatin decreases expression ISO RGD:2307384 6480464 Cisplatin results in decreased expression of ANKRD33B mRNA CTD PMID:27594783 copper atom decreases expression ISO RGD:1558105 6480464 Copper results in decreased expression of ANKRD33B mRNA CTD PMID:17205981 copper(0) decreases expression ISO RGD:1558105 6480464 Copper results in decreased expression of ANKRD33B mRNA CTD PMID:17205981 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ANKRD33B mRNA CTD PMID:26577399 dorsomorphin multiple interactions ISO RGD:2307384 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1558105 6480464 Doxorubicin results in decreased expression of ANKRD33B mRNA CTD PMID:19277126 doxorubicin decreases expression ISO RGD:2307384 6480464 Doxorubicin results in decreased expression of ANKRD33B mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:2307384 6480464 entinostat results in increased expression of ANKRD33B mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:2307384 6480464 Ethanol results in increased expression of ANKRD33B mRNA CTD PMID:28986285 ethanol affects splicing ISO RGD:1558105 6480464 Ethanol affects the splicing of ANKRD33B mRNA CTD PMID:30319688 lead diacetate increases expression ISO RGD:1558105 6480464 lead acetate results in increased expression of ANKRD33B mRNA CTD PMID:25270620 leflunomide increases expression ISO RGD:2307384 6480464 leflunomide results in increased expression of ANKRD33B mRNA CTD PMID:28988120 mercury dibromide increases expression ISO RGD:2307384 6480464 mercuric bromide results in increased expression of ANKRD33B mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:2307384 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD33B mRNA CTD PMID:27188386 methylmercury chloride increases expression ISO RGD:2307384 6480464 methylmercuric chloride results in increased expression of ANKRD33B mRNA CTD PMID:28001369 paracetamol decreases expression ISO RGD:2307384 6480464 Acetaminophen results in decreased expression of ANKRD33B mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ANKRD33B mRNA CTD PMID:32479839 paracetamol increases expression ISO RGD:2307384 6480464 Acetaminophen results in increased expression of ANKRD33B mRNA CTD PMID:29067470 phenylmercury acetate increases expression ISO RGD:2307384 6480464 Phenylmercuric Acetate results in increased expression of ANKRD33B mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:2307384 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD33B mRNA CTD PMID:27188386 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:2307384 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of ANKRD33B mRNA CTD PMID:33725128 SB 431542 multiple interactions ISO RGD:2307384 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite increases expression ISO RGD:2307384 6480464 sodium arsenite results in increased expression of ANKRD33B mRNA CTD PMID:29301061 sodium fluoride increases expression ISO RGD:1558105 6480464 Sodium Fluoride results in increased expression of ANKRD33B mRNA CTD PMID:27862939 sunitinib decreases expression ISO RGD:2307384 6480464 Sunitinib results in decreased expression of ANKRD33B mRNA CTD PMID:31533062 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ANKRD33B mRNA CTD PMID:23411599 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ANKRD33B mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1558105 6480464 titanium dioxide results in decreased expression of ANKRD33B mRNA CTD PMID:23557971 triclosan decreases expression ISO RGD:2307384 6480464 Triclosan results in decreased expression of ANKRD33B mRNA CTD PMID:30510588 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of ANKRD33B mRNA CTD PMID:30589522 troglitazone decreases expression ISO RGD:1558105 6480464 troglitazone results in decreased expression of ANKRD33B mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:1558105 6480464 Tungsten results in decreased expression of ANKRD33B mRNA CTD PMID:30912803 urethane increases expression ISO RGD:2307384 6480464 Urethane results in increased expression of ANKRD33B mRNA CTD PMID:28818685 valproic acid increases methylation ISO RGD:2307384 6480464 Valproic Acid results in increased methylation of ANKRD33B gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1558105 6480464 Valproic Acid affects the expression of ANKRD33B mRNA CTD PMID:17292431 valproic acid increases expression ISO RGD:2307384 6480464 Valproic Acid results in increased expression of ANKRD33B mRNA CTD PMID:23179753 , PMID:28001369 valproic acid affects expression ISO RGD:2307384 6480464 Valproic Acid affects the expression of ANKRD33B mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ANKRD33B mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ANKRD33B mRNA CTD PMID:30207508 vincristine increases expression ISO RGD:2307384 6480464 Vincristine results in increased expression of ANKRD33B mRNA CTD PMID:23649840
References
Genomics
Comparative Map Data
Ankrd33b Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl mRatBN7.2 2 82,277,604 - 82,359,420 (-) NCBI mRatBN7.2 mRatBN7.2 Ensembl 2 82,283,108 - 82,358,872 (-) Ensembl Rnor_6.0 2 84,361,061 - 84,436,912 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 84,361,061 - 84,437,084 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 104,034,185 - 104,110,203 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 83,369,613 - 83,446,622 (-) NCBI RGSC3.4 rn4 RGSC3.4 Celera 2 77,806,510 - 77,882,181 (-) NCBI Celera Cytogenetic Map 2 q22 NCBI
ANKRD33B Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 5 10,564,070 - 10,657,816 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p13 Ensembl 5 10,564,070 - 10,657,816 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 5 10,564,182 - 10,657,928 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 5 10,615,464 - 10,703,225 (+) NCBI NCBI36 hg18 NCBI36 Celera 5 10,602,518 - 10,695,071 (+) NCBI Cytogenetic Map 5 p15.2 NCBI HuRef 5 10,548,592 - 10,640,738 (+) NCBI HuRef CHM1_1 5 10,564,397 - 10,657,792 (+) NCBI CHM1_1 T2T-CHM13v2.0 5 10,503,260 - 10,595,837 (+) NCBI
Ankrd33b Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 15 31,278,328 - 31,370,446 (-) NCBI GRCm39 mm39 GRCm39 Ensembl 15 31,291,624 - 31,367,872 (-) Ensembl GRCm38 15 31,291,479 - 31,367,802 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 15 31,291,478 - 31,367,726 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 15 31,221,234 - 31,297,514 (-) NCBI GRCm37 mm9 NCBIm37 MGSCv36 15 31,241,253 - 31,312,154 (-) NCBI mm8 Celera 15 31,976,877 - 32,055,999 (-) NCBI Celera Cytogenetic Map 15 B2 NCBI
Ankrd33b Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955426 363,297 - 384,415 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955426 363,297 - 383,013 (+) NCBI ChiLan1.0 ChiLan1.0
ANKRD33B
ANKRD33B Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 34 3,698,806 - 3,780,942 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 34 3,704,756 - 3,782,120 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 34 8,202,771 - 8,284,369 (-) NCBI ROS_Cfam_1.0 34 3,604,295 - 3,685,993 (-) NCBI ROS_Cfam_1.0 Ensembl 34 3,608,534 - 3,686,201 (-) Ensembl UMICH_Zoey_3.1 34 3,654,446 - 3,736,021 (-) NCBI UNSW_CanFamBas_1.0 34 3,632,005 - 3,714,404 (-) NCBI UU_Cfam_GSD_1.0 34 3,863,692 - 3,945,438 (-) NCBI
Ankrd33b Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024407213 236,561,085 - 236,786,441 (-) NCBI SpeTri2.0 NW_004936643 2,617,458 - 2,754,779 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
ANKRD33B
ANKRD33B Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 4 10,092,511 - 10,183,437 (+) NCBI ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 4 10,092,651 - 10,175,664 (+) Ensembl ChlSab1.1 chlSab2 Vero_WHO_p1.0 NW_023666064 18,361,391 - 18,452,231 (-) NCBI Vero_WHO_p1.0
Ankrd33b
Position Markers
D2Rat95
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 82,316,452 - 82,316,662 (+) MAPPER mRatBN7.2 Rnor_6.0 2 84,394,688 - 84,394,897 NCBI Rnor6.0 Rnor_5.0 2 104,067,812 - 104,068,021 UniSTS Rnor5.0 RGSC_v3.4 2 83,403,024 - 83,403,435 RGD RGSC3.4 RGSC_v3.4 2 83,403,087 - 83,403,296 UniSTS RGSC3.4 RGSC_v3.1 2 83,348,049 - 83,348,258 RGD Celera 2 77,839,883 - 77,840,092 UniSTS RH 3.4 Map 2 516.6 RGD RH 3.4 Map 2 516.6 UniSTS RH 2.0 Map 2 419.5 RGD SHRSP x BN Map 2 33.1398 RGD Cytogenetic Map 2 q22 UniSTS
D2Rat277
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 82,345,893 - 82,346,118 (+) MAPPER mRatBN7.2 Rnor_6.0 2 84,424,139 - 84,424,363 NCBI Rnor6.0 Rnor_5.0 2 104,097,430 - 104,097,654 UniSTS Rnor5.0 RGSC_v3.4 2 83,433,833 - 83,434,058 RGD RGSC3.4 RGSC_v3.4 2 83,433,834 - 83,434,058 UniSTS RGSC3.4 RGSC_v3.1 2 83,378,795 - 83,379,020 RGD Celera 2 77,869,393 - 77,869,617 UniSTS SHRSP x BN Map 2 33.1798 RGD SHRSP x BN Map 2 33.1798 UniSTS Cytogenetic Map 2 q22 UniSTS
BF405011
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 82,283,025 - 82,283,236 (+) MAPPER mRatBN7.2 Rnor_6.0 2 84,361,014 - 84,361,224 NCBI Rnor6.0 Rnor_5.0 2 104,034,138 - 104,034,348 UniSTS Rnor5.0 RGSC_v3.4 2 83,369,566 - 83,369,776 UniSTS RGSC3.4 Celera 2 77,806,463 - 77,806,673 UniSTS Cytogenetic Map 2 q22 UniSTS
RH139337
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 82,347,082 - 82,347,202 (+) MAPPER mRatBN7.2 Rnor_6.0 2 84,425,328 - 84,425,447 NCBI Rnor6.0 Rnor_5.0 2 104,098,619 - 104,098,738 UniSTS Rnor5.0 RGSC_v3.4 2 83,435,023 - 83,435,142 UniSTS RGSC3.4 Celera 2 77,870,582 - 77,870,701 UniSTS Cytogenetic Map 2 q22 UniSTS
AI412966
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 82,282,613 - 82,282,794 (+) MAPPER mRatBN7.2 Rnor_6.0 2 84,360,602 - 84,360,782 NCBI Rnor6.0 Rnor_5.0 2 104,033,726 - 104,033,906 UniSTS Rnor5.0 RGSC_v3.4 2 83,369,154 - 83,369,334 UniSTS RGSC3.4 Celera 2 77,806,051 - 77,806,231 UniSTS RH 3.4 Map 2 516.3 UniSTS Cytogenetic Map 2 q22 UniSTS
QTLs in Region (mRatBN7.2)
61355 Bp36 Blood pressure QTL 36 2.9 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 2 5873687 102844969 Rat 1302794 Stl27 Serum triglyceride level QTL 27 4.4 0.0001 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 2 25413423 143657569 Rat 1358894 Kidm24 Kidney mass QTL 24 4.03 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358899 Kidm23 Kidney mass QTL 23 3.88 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358901 Cm38 Cardiac mass QTL 38 2 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 157142209 Rat 1358904 Cm39 Cardiac mass QTL 39 2.26 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 157142209 Rat 1358910 Kidm27 Kidney mass QTL 27 5.77 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358911 Kidm28 Kidney mass QTL 28 5.42 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358913 Cm41 Cardiac mass QTL 41 2.73 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 1358917 Cm42 Cardiac mass QTL 42 2.82 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 1358887 Bw50 Body weight QTL 50 2.39 body mass (VT:0001259) body weight (CMO:0000012) 2 25413652 157142078 Rat 1358908 Bw49 Body weight QTL 49 3.36 body mass (VT:0001259) body weight (CMO:0000012) 2 25413652 157142078 Rat 1354603 Bp243 Blood pressure QTL 243 3.9 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 26917817 127469484 Rat 2290453 Scl55 Serum cholesterol level QTL 55 2.83 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 2 26917817 136917119 Rat 61371 Edpm1 Estrogen-dependent pituitary mass QTL 1 4 0.05 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 2 35134841 88029593 Rat 70174 BpQTLCluster2 Blood pressure QTL cluster 2 4.24 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 40067944 102785628 Rat 70174 BpQTLCluster2 Blood pressure QTL cluster 2 4.24 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 40067944 102785628 Rat 70174 BpQTLCluster2 Blood pressure QTL cluster 2 4.24 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 40067944 102785628 Rat 70174 BpQTLCluster2 Blood pressure QTL cluster 2 4.24 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 2 40067944 102785628 Rat 70174 BpQTLCluster2 Blood pressure QTL cluster 2 4.24 arterial blood pressure trait (VT:2000000) absolute change in mean arterial blood pressure (CMO:0000533) 2 40067944 102785628 Rat 2293835 Kiddil5 Kidney dilation QTL 5 3.8 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 157142209 Rat 2293843 Kiddil6 Kidney dilation QTL 6 3.1 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 182042367 Rat 1298074 Bp164 Blood pressure QTL 164 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 1298085 Bp165 Blood pressure QTL 165 0.0006 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 61467 Bp14 Blood pressure QTL 14 2.2 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 43154682 202446871 Rat 61467 Bp14 Blood pressure QTL 14 2.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 43154682 202446871 Rat 2293676 Bmd19 Bone mineral density QTL 19 10.7 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 2 43162366 111362592 Rat 2293682 Bmd24 Bone mineral density QTL 24 8.9 0.0001 femur mineral mass (VT:0010011) cortical volumetric bone mineral density (CMO:0001730) 2 43162366 111362592 Rat 2293671 Bss44 Bone structure and strength QTL 44 10.97 0.0001 lumbar vertebra morphology trait (VT:0010494) lumbar vertebra cortical cross-sectional area (CMO:0001690) 2 43162366 148478373 Rat 631208 Bw1 Body weight QTL1 5.09 mesenteric fat pad mass (VT:0010427) mesenteric fat pad weight to body weight ratio (CMO:0000654) 2 43171017 83575226 Rat 1354601 Slep1 Serum leptin concentration QTL 1 5.39 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 2 43171017 184114403 Rat 631266 Bp132 Blood pressure QTL 132 0.0005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 46123260 202447032 Rat 1331760 Bp206 Blood pressure QTL 206 3.62454 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 56043031 202447032 Rat 1558648 Smcn1 Smooth muscle cell number QTL 1 0.039 blood vessel smooth muscle cell quantity (VT:0010525) aorta smooth muscle cell count per unit vessel length (CMO:0001646) 2 59134147 127460910 Rat 5684990 Bmd82 Bone mineral density QTL 82 2.8 tibia mineral mass (VT:1000283) bone mineral content (CMO:0001554) 2 59324377 103795077 Rat 5684996 Bmd85 Bone mineral density QTL 85 4.7 0.024 tibia mineral mass (VT:1000283) bone mineral density (CMO:0001226) 2 59324377 103795077 Rat 61438 Cia7 Collagen induced arthritis QTL 7 4.6 0.0001 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 2 59324377 141596857 Rat 631500 Bp99 Blood pressure QTL 99 2.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 59324719 102755241 Rat 1578777 Stresp15 Stress response QTL 15 2 0.05 blood aldosterone amount (VT:0005346) plasma aldosterone level (CMO:0000551) 2 59846005 104846005 Rat 2306903 Bp336 Blood pressure QTL 336 0.01 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 64366971 109366971 Rat 1298080 Bp163 Blood pressure QTL 163 0.02 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 66118275 202447032 Rat 1354648 Bp239 Blood pressure QTL 239 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 66118463 226797303 Rat 7411551 Bw131 Body weight QTL 131 29.6 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 2 67942638 112942638 Rat 1558653 Prcr1 Prostate cancer resistance QTL 1 5 prostate integrity trait (VT:0010571) area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) 2 72532993 157142209 Rat 1359034 Bp274 Blood pressure QTL 274 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 74786664 94359546 Rat 1359034 Bp274 Blood pressure QTL 274 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 74786664 94359546 Rat 1354605 Rf48 Renal function QTL 48 2.9 blood creatinine amount (VT:0005328) plasma creatinine level (CMO:0000537) 2 74786664 206665859 Rat 61465 Bp13 Blood pressure QTL 13 3.3 blood pressure trait (VT:0000183) diastolic blood pressure (CMO:0000005) 2 76539322 102785628 Rat 61465 Bp13 Blood pressure QTL 13 3.3 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 2 76539322 102785628 Rat 631198 Cm22 Cardiac mass QTL 22 4.3 0.0008 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 2 76539322 150540526 Rat 61374 Edpm2 Estrogen-dependent pituitary mass QTL 2 4.42 0.86 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 2 76539322 202447032 Rat 2299162 Iddm32 Insulin dependent diabetes mellitus QTL 32 2.36 blood glucose amount (VT:0000188) age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) 2 78665616 143657569 Rat 1581569 Uae32 Urinary albumin excretion QTL 32 0.0001 urine protein amount (VT:0005160) urine albumin excretion rate (CMO:0000757) 2 78665619 219826953 Rat 724534 Uae6 Urinary albumin excretion QTL 6 10 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 2 78665619 249053267 Rat 61392 Bp6 Blood pressure QTL 6 7 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 2 80270434 125270434 Rat 1598865 Bp296 Blood pressure QTL 296 2.1 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 81018907 126018907 Rat 8662832 Vetf7 Vascular elastic tissue fragility QTL 7 3.5 aorta elastin amount (VT:0003905) aorta wall extracellular elastin dry weight to aorta wall dry weight ratio (CMO:0002002) 2 81689826 221035911 Rat 1354622 Kidm16 Kidney mass QTL 16 3 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 2 81754530 222436696 Rat 1354649 Kidm17 Kidney mass QTL 17 2.9 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 2 81754530 227146641 Rat 1578772 Stresp14 Stress response QTL 14 5 0.001 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 2 82345893 130923501 Rat 
